期刊文献+

葛根总黄酮分散片的药动学研究及其与愈风宁心片的比较 被引量:3

Comparison of Pharmacokinetics Between Yufeng Ningxin Tablet and Disperible Tablets of Pueraria lobata Flavone
原文传递
导出
摘要 目的:研究葛根总黄酮分散片在大鼠体内的药代动力学特征及生物利用度,并与市售愈风宁心片进行比较。方法:大鼠灌胃给药葛根总黄酮分散片(受试制剂)及市售片(参比制剂)混悬液,采用HPLC测定给药后各时间点的血药浓度,用统计软件计算主要药代动力学参数。结果:分散片与市售片的C max分别为(20.21±0.18),(9.90±0.25)mg·L-1;分散片的T max=(0.50±0.03)h,市售片T max=(1.09±0.02)h;分散片相对于市售片的生物利用度为182.68%。结论:葛根总黄酮分散片吸收快,起效时间明显提前,生物利用度明显优于市售片。 Objective: To study and compare the serum concentration and pharmacokinetics of disperible tablets of Pueraria lobata flavone and Yufeng Ningxin tablet in rats. Method: The mice were given disperible tablets of Pueraria lobata flavone and Yufeng Ningxin tablet, HPLC was used to test the serum concentration at different time points and design conditions of pharmacokinetics by statistical software. Result: The Cmax of disperible tablets of Pueraria lobata flavone and merchant tablet was (20.21 ± 0. 18), (9.90 ± 0.25 ) mg.L^-1 The dispersible tablet T was (0.50 ± 0.03) h, merchant tablet being ( 1.09 ± 0.02) h. Conclusion: Disperible tablets of Pueraria lobata flavone has rapid absorbtion, the onset time was rapaid and the pharmacokinetics was superior to the control group.
出处 《中国实验方剂学杂志》 CAS 北大核心 2014年第1期107-110,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 广东省高等学校大学生创新实验项目(1057310021)
关键词 葛根总黄酮 分散片 愈风宁心片 血药浓度 药代动力学 Pueraria lobata flavone dispersible tablet Yufeng Ningxin tablet serum concentration pharmacokinetics
  • 相关文献

参考文献5

二级参考文献87

共引文献164

同被引文献37

  • 1戚本明,蔡春春,邓小明,张林.葛根总黄酮对卵巢切除大鼠鼻黏膜上皮细胞凋亡的保护作用[J].中国中药杂志,2005,30(11):855-857. 被引量:4
  • 2李运景.葛根素注射液不良反应分析[J].中国药房,2006,17(24):1895-1897. 被引量:10
  • 3崔升淼,赵春顺,高坤,毛晶晶,何仲贵.大鼠肝微粒体中葛根素的液相色谱-质谱测定法及药物代谢动力学[J].沈阳药科大学学报,2007,24(1):32-36. 被引量:27
  • 4张志荣,游学均,魏振平,何勤,李少伟.愈风宁心胶囊在兔体内的药动学和生物利用度研究[J].中国药学杂志,1997,32(4):224-226. 被引量:31
  • 5Mehnert W, Mader K.Solid lipid nanoparticles Production, characterization and applications[J].Adv Drug Deliv Prey,2012,64: 83-101.
  • 6Burra M, Jukanti R, Yadav Janga K, et al.Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles[J]. Adv Powder Technol,2013,24: 393-402.
  • 7Matilde DL, Alicia EG, Mercedes FA, et al.Statistical analysis of solid lipid nanoparticles produced by high- pressure homogenization: a practical prediction approach[J].J Nanopart Res,2013,15:1443.
  • 8Kumar S, Randhawa JK.Preparation and characterization of Paliperidone loaded solid lipid nanoparticles[J].Colloids Surf B : Biointerfaces, 2013,102 : 562-568.
  • 9Silva AC, Gonz a lez-Mira E, Garc i a ML, et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanopartieles ( SLN ) : high pressure homogenization versus uhrasound[J].Colloids Surf B : Biointerfaces, 2011,86: 158-165.
  • 10国家药典委员会.中华人民共和国药典:一部[S].2015年版.北京:中国医药科技出版社,2015:301、附录34.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部